***** seminarMLから情報転載 *****


10/12 臨床研セミナーのご案内 1
(Mauro Giacca博士)


東京都臨床医学総合研究所にて、以下のとおりセミナーを行います。
参加登録不要・無料ですので、ご興味のおありの方は直接会場にお越しください。
皆様のご来聴をお待ちしております。

-----------------------------------

日時 :平成17年10月12日(水曜日) 14:00?15:30
会場 :(財)東京都医学研究機構 東京都臨床医学総合研究所 2階会議室
JR「田端駅」下車 徒歩12分
地下鉄南北線「本駒込駅」下車 徒歩12分
http://www.rinshoken.or.jp/frm/f_map.htm
演題 :Induction of functional neovascularization by gene therapy using AAV vectors
演者:Mauro Giacca(Director&s_comma; International Centre for Genetic Engineering and Biotechnology [ICGEB]&s_comma; Trieste&s_comma; Italy)

Mauro Giacca博士は北イタリアのトリエステ市にあるICGEBの所長として、DNA複製、HIV感染、遺伝子治療など幅広い分野で活躍されております。
今回、細胞周期に関連するシンポジウムに招聘され日本を訪問されておりますが、本セミナーでは、AAVを用いた遺伝子治療についての最新の知見についてお話いただきます。


The potential to induce therapeutic angiogenesis and myocardial cell regeneration through gene transfer has engendered much excitement for the possible treatment of ischemic tissues. However&s_comma; a number of crucial issues have still to be solved before successful clinical application&s_comma; including the understanding of whether functional blood vessels can arise as a result of the delivery of a single angiogenic factor&s_comma; or of which are the most suitable vectors for efficient&s_comma; stable and controllable gene delivery to the heart. In this respect&s_comma; the peculiar tropism of vectors based on the adeno-associated virus (AAV) for skeletal and cardiac muscle&s_comma; together with their ability to sustain long term expression are very appealing characteristics for cardiovascular gene therapy. We have recently observed that the delivery of an AAV vector expressing the 165 aa isoform of VEGF (VEGF165) into the skeletal muscle and heart of rodents induces an impressive formation of new capillaries and arteriolae with a 20-120 µm diameter. However&s_comma; these vessels were leaky&s_comma; poorly organized and did not account for the better perfusion of the muscle&s_comma; as indicated by permeability tests and in vivo PET imaging. Strikingly&s_comma; the functional competence of these vessels could be significantly improved by the simultaneous delivery of AAV-Angiopoietin1&s_comma; a factor that is involved in vessel maturation. In the course of these experiments&s_comma; we also noticed that the foci of VEGF neovascularization were always massively infiltrated with CD45+&s_comma; CD11b+ mononuclear cells. These cells were found to derive from the bone marrow (as detected by bone marrow transplantation and FISH analysis) and to be recruited to the sites of new blood vessel formation through the interaction of VEGF165 with the neuropilin-1 (NP-1) co-receptor&s_comma; as shown by specific siRNA knock down of the NP-1 mRNA. The presence of these mononuclear cells was found to strictly correlate with arteriogenesis: in the case of the delivery of another VEGF isoform (VEGF121)&s_comma; which does not bind NP-1&s_comma; neither cellular infiltrates nor arterial vessels were evident. Thus&s_comma; the recruitment of bone marrow mononuclear cells is essential for arterial formation; in no case&s_comma; however&s_comma; these cells were ever found incorporated in the newly formed vasculature&s_comma; thus ruling out that VEGF165 might trigger a vasculogenesis process sustained by bone marrow-derived progenitors.

世話人:正井久雄
-----
東京都臨床医学総合研究所
ゲノム動態プロジェクト
Tel: 03-5685-2264; Fax: 03-5685-2932



seminarMLに関する情報は「バイオ関係者、皆のホームページ」特選MailingList_Forum欄でアクセスできる。